On this note, the European Randomized Study of Screening for Prostate Cancer has reported that 22%–43% of the PSA-detected malignancies are overdiagnosed (Hugosson et al., 2019) which leads to unnecessary biopsies and over-treatment. This evidence concerns the gene KLK3 and cancer.